CC BY 4.0 · Rev Bras Ginecol Obstet 2020; 42(04): 218-227
DOI: 10.1055/s-0040-1708096
Review Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Thromboprophylaxis during the Pregnancy-Puerperal Cycle - Literature Review

Tromboprofilaxia no ciclo gravídico-puerperal – Revisão da literatura
1   Santa Casa da Bahia, Salvador, BA, Brazil
,
2   Universidade do Estado da Bahia, Salvador, BA, Brazil
,
3   Universidade Federal da Bahia, Salvador, BA, Brasil
,
4   Sociedade Brasileira de Angiologia e Cirurgia Vascular, Salvador, BA, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

02. September 2019

21. Januar 2020

Publikationsdatum:
24. April 2020 (online)

Abstract

Objective To identify current strategies and recommendations for venous thromboembolism prophylaxis associated with the pregnancy-puerperal cycle, a condition of high morbidity and mortality among women.

Methods The literature search was performed between May and October 2019, using the PubMed database, including papers published in Portuguese, English and Spanish. The terms thromboembolism (Mesh) AND pregnancy (Mesh) OR postpartum (Mesh) were used as descriptors, including randomized controlled trials, meta-analyses, systematic reviews and guidelines published from 2009 to 2019, presenting strategies for prevention of thromboembolism during pregnancy and the postpartum.

Results Eight articles met the inclusion criteria. Many studies evaluated were excluded because they did not address prevention strategies. We compiled the recommendations from the American Society of Hematologists, the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynecologists, the Society of Obstetricians and Gynaecologists of Canada, the American College of Chest Physicians and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Conclusion: There are some gaps in the research, and clinical studies with appropriate methodology are needed to support decisions made regarding the risk of thromboembolism in the perigestational period. Thus, the attention of the professionals involved in the care of pregnant and postpartum women is crucial, as it is a condition associated with high morbidity and mortality.

Resumo

Objetivo Identificar as estratégias e recomendações atuais para profilaxia de tromboembolismo venoso associado ao ciclo gravídico-puerperal, condição de alta morbimortalidade entre mulheres.

Métodos A busca na literatura ocorreu entre maio e outubro de 2019, com pesquisa na base de dados do PubMed, contemplando trabalhos publicados nos idiomas português, inglês e espanhol. Os termos thromboembolism (Mesh) AND pregnancy (Mesh) OR postpartum (Mesh) foram utilizados como descritores, incluindo ensaios clínicos randomizados, metanálises, revisões sistemáticas e diretrizes publicadas entre 2009 a 20019, apresentando estratégias de prevenção de tromboembolismo venoso durante a gravidez e o pós-parto.

Resultados Oito artigos abordando estratégias de tromboprofilaxia primária e secundária durante a gestação, parto e puerpério foram selecionados para a presente revisão sistemática. Muitos estudos avaliados foram excluídos por não abordarem estratégias de prevenção. Foram compiladas as recomendações das seguintes sociedades: American Society of Hematologists, American College of Obstetricians and Gynecologists, Royal College of Obstetricians and Gynecologists, Society of Obstetricians and Gynaecologists of Canada, American College of Chest Physicians e Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Conclusão Até o presente momento, há algumas lacunas e estudos clínicos com metodologia adequada se fazem necessários para respaldar a tomada de decisão frente ao risco de tromboembolismo venoso no período perigestacional. Torna-se fundamental a atenção dos profissionais envolvidos no atendimento às gestantes e puérperas, pois trata-se de uma condição associada a alta morbimortalidade.

 
  • References

  • 1 Friedman AM, Ananth CV. Obstetrical venous thromboembolism: Epidemiology and strategies for prophylaxis. Semin Perinatol 2016; 40 (02) 81-86 . Doi: 10.1053/j.semperi.2015.11.011
  • 2 Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367 9516 1066-1074 . Doi: 10.1016/S0140-6736(06)68397-9
  • 3 Meng K, Hu X, Peng X, Zhang Z. Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2015; 28 (03) 245-253 . Doi: 10.3109/14767058.2014.913130
  • 4 Dargaud Y, Rugeri L, Fleury C, Battie C, Gaucherhand P, Huissoud C. , et al. Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study. J Thromb Haemost 2017; 15 (05) 897-906 . Doi: 10.1111/jth.13660
  • 5 Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999; 54 (04) 265-271 . Doi: 10.1097/00006254-199904000-00023
  • 6 Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJM. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008; 6 (04) 632-637 . Doi: 10.1111/j.1538-7836.2008.02921.x
  • 7 Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol 2011; 117 (03) 691-703 . Doi: 10.1097/AOG.0b013e31820ce2db
  • 8 ACOG Practice Bulletin No 196: thromboembolism in pregnancy. Obstet Gynecol 2018; 132 (01) e1-e17 . Doi: 10.1097/AOG.0000000000002706
  • 9 Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol 2012; 120 (05) 1029-1036 . Doi: 10.1097/aog.0b013e31826d60c5
  • 10 Abe K, Kuklina EV, Hooper WC, Callaghan WM. Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States. Semin Perinatol 2019; 43 (04) 200-204 . Doi: 10.1053/j.semperi.2019.03.004
  • 11 James AH. Thrombosis in pregnancy and maternal outcomes. Birth Defects Res C Embryo Today 2015; 105 (03) 159-166 . Doi: 10.1002/bdrc.21106
  • 12 Wik HS, Jacobsen AF, Sandvik L, Sandset PM. Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study. BMJ Open 2012; 2 (06) e002048 . Doi: 10.1136/bmjopen-2012-002048
  • 13 Reducing the risk of venous thrombosis and embolism during pregnancy and the puerperium [Internet]. London: Royal College of Obstetricians & Gynaecologists; Apr 2015 [cited 2019 Oct 19]. (Green-top Guideline No. 37a). Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/
  • 14 Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH. , et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv 2018; 2 (22) 3317-3359 . Doi: 10.1182/bloodadvances.2018024802
  • 15 ACOG Practice Bulletin No 197 Summary: inherited thrombophilias in pregnancy. Obstet Gynecol 2018; 132 (01) 249-251 . Doi: 10.1097/AOG.0000000000002705
  • 16 Chan WS, Rey E, Kent NE, Corbett T, David M, Douglas MG. , et al; VTE in Pregnancy Guideline Working Group; Society of Obstetricians and Gynecologists of Canada Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can 2014; 36 (06) 527-553
  • 17 Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 ( 2 Suppl): e691S-e736S . Doi: 10.1378/chest.11-2300 PubMed
  • 18 McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S. , et al; Councils of the Society of Obstetric Medicine of Australia and New Zealand; Australasian Society of Thrombosis and Haemostasis Recommendations for the prevention of pregnancy-associated venous thromboembolism. Aust N Z J Obstet Gynaecol 2012; 52 (01) 3-13 . Doi: 10.1111/j.1479-828X.2011.01357.x
  • 19 Stephenson ML, Serra AE, Neeper JM, Caballero DC, McNulty J. A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women. J Perinatol 2016; 36 (02) 95-99 . Doi: 10.1038/jp.2015.130
  • 20 Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J 1996; 41 (03) 83-86 . Doi: 10.1177/003693309604100305
  • 21 Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16 (02) 153-168 . Doi: 10.1016/s1521-6926(03)00021-5
  • 22 Guimicheva B, Czuprynska J, Arya R. The prevention of pregnancy-related venous thromboembolism. Br J Haematol 2015; 168 (02) 163-174 . Doi: 10.1111/bjh.13159
  • 23 Büchtemann AS, Steins A, Volkert B, Hahn M, Klyscz T, Jünger M. The effect of compression therapy on venous haemodynamics in pregnant women. Br J Obstet Gynaecol 1999; 106 (06) 563-569 . Doi: 10.1111/j.1471-0528.1999.tb08325.x
  • 24 Jamieson R, Calderwood CJ, Greer IA. The effect of graduated compression stockings on blood velocity in the deep venous system of the lower limb in the postnatal period. BJOG 2007; 114 (10) 1292-1294 . Doi: 10.1111/j.1471-0528.2007.01421.x
  • 25 Morris RJ, Woodcock JP. Evidence-based compression: prevention of stasis and deep vein thrombosis. Ann Surg 2004; 239 (02) 162-171 . Doi: 10.1097/01.sla.0000109149.77194.6c
  • 26 Kolettis D, Craigo S. Thromboprophylaxis in Pregnancy. Obstet Gynecol Clin North Am 2018; 45 (02) 389-402 . Doi: 10.1016/j.ogc.2018.01.007
  • 27 Wu P, Poole TC, Pickett JA, Bhat A, Lees CC. Current obstetric guidelines on thromboprophylaxis in the United Kingdom: evidence based medicine?. Eur J Obstet Gynecol Reprod Biol 2013; 168 (01) 7-11 . Doi: 10.1016/j.ejogrb.2012.12.022
  • 28 Chauleur C, Gris JC, Laporte S, Chapelle C, Bertoletti L, Equy V. , et al; STRATHEGE Investigators and The STRATHEGE Group Benefit of risk score-guided prophylaxis in pregnant women at risk of thrombotic events: a controlled before-and-after implementation study. Thromb Haemost 2018; 118 (09) 1564-1571 . Doi: 10.1055/s-0038-1668524
  • 29 Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106 (02) 401-407 . Doi: 10.1182/blood-2005-02-0626
  • 30 Rodger MA, Kahn SR, Cranney A, Hodsman A, Kovacs MJ, Clement AM. , et al; TIPPS investigators Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost 2007; 5 (08) 1600-1606 . Doi: 10.1111/j.1538-7836.2007.02634.x
  • 31 Casele H, Haney EI, James A, Rosene-Montella K, Carson M. Bone density changes in women who receive thromboprophylaxis in pregnancy. Am J Obstet Gynecol 2006; 195 (04) 1109-1113 . Doi: 10.1016/j.ajog.2006.06.080
  • 32 Leffert L, Butwick A, Carvalho B, Arendt K, Bates SM, Friedman A. , et al; members of the SOAP VTE Taskforce The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg 2018; 126 (03) 928-944 . Doi: 10.1213/ANE.0000000000002530
  • 33 Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnely J, Verhamme P. , et al. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses. Thromb Res 2016; 144: 62-68 . Doi: 10.1016/j.thromres.2016.06.001
  • 34 Boban A, Paulus S, Lambert C, Hermans C. The value and impact of anti-Xa activity monitoring for prophylactic dose adjustment of low-molecular-weight heparin during pregnancy: a retrospective study. Blood Coagul Fibrinolysis 2017; 28 (03) 199-204 . Doi: 10.1097/MBC.0000000000000573
  • 35 Lussana F, Coppens M, Cattaneo M, Middeldorp S. Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis. Thromb Res 2012; 129 (06) 673-680 . Doi: 10.1016/j.thromres.2012.01.017
  • 36 Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D. , et al. Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 (Suppl (Suppl. 01) 1-203 . Doi: 10.1111/j.1471-0528.2010.02847.x
  • 37 Friedman AM, D'Alton ME. Venous thromboembolism bundle: Risk assessment and prophylaxis for obstetric patients. Semin Perinatol 2016; 40 (02) 87-92 . Doi: 10.1053/j.semperi.2015.11.012
  • 38 Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M, Smith NL. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest 2016; 150 (03) 572-596 . Doi: 10.1016/j.chest.2016.05.021
  • 39 Fonseca NM, Alves RR, Pontes JPJ. ; Sociedade Brasileira de Anestesiologia SBA recommendations for regional anesthesia safety in patients taking anticoagulants. Braz J Anesthesiol 2014; 64 (01) 1-15 . Doi: 10.1016/j.bjane.2013.04.010
  • 40 Prevention and management of postpartum haemorrhage. BJOG 2017; 124 (05) e106-e149 . Doi: 10.1111/1471-0528.14178